フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference PR Newswire RANCHO CORDOVA, Calif., Sept. 3, 2019...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FOR...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...
Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update Revenue Grows by 115% and the Company...
Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13 PR...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II System PR Newswire RANCHO CORDOVA, Calif., July 23, 2019 RANCHO...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
Cesca Therapeutics Regains Nasdaq Listing Compliance PR Newswire RANCHO CORDOVA, Calif., June 26, 2019 RANCHO CORDOVA, Calif., June 26, 2019...
Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India PR Newswire RANCHO CORDOVA, Calif., June 25...
ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing Marks Second Product Approval from...
ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium Company to promote its...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約